BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 9539782)

  • 1. Detection and characterization of carcinoma cells in the blood.
    Racila E; Euhus D; Weiss AJ; Rao C; McConnell J; Terstappen LW; Uhr JW
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4589-94. PubMed ID: 9539782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immunomagnetic epithelial tumor cell enrichment model for minimal residual disease detection of cytokeratin 8+ malignancies.
    Brooimans RA; de Leeuw N; Bontenbal M; Gratama JW
    J Biol Regul Homeost Agents; 2005; 19(1-2):84-91. PubMed ID: 16178280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometry--principles and feasibility in transfusion medicine. Enumeration of epithelial derived tumor cells in peripheral blood.
    Terstappen LW; Rao C; Gross S; Kotelnikov V; Racilla E; Uhr J; Weiss A
    Vox Sang; 1998; 74 Suppl 2():269-74. PubMed ID: 9704456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of carcinoma cells in the blood of breast cancer patients.
    Beitsch PD; Clifford E
    Am J Surg; 2000 Dec; 180(6):446-8; discussion 448-9. PubMed ID: 11182395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomagnetic enrichment of disseminated epithelial tumor cells from peripheral blood by MACS.
    Martin VM; Siewert C; Scharl A; Harms T; Heinze R; Ohl S; Radbruch A; Miltenyi S; Schmitz J
    Exp Hematol; 1998 Mar; 26(3):252-64. PubMed ID: 9502622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow.
    Pantel K; Schlimok G; Angstwurm M; Weckermann D; Schmaus W; Gath H; Passlick B; Izbicki JR; Riethmüller G
    J Hematother; 1994; 3(3):165-73. PubMed ID: 7530132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and quantification of circulating tumor cells in mouse models of human breast cancer using immunomagnetic enrichment and multiparameter flow cytometry.
    Allan AL; Vantyghem SA; Tuck AB; Chambers AF; Chin-Yee IH; Keeney M
    Cytometry A; 2005 May; 65(1):4-14. PubMed ID: 15810015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell filtration-laser scanning cytometry for the characterisation of circulating breast cancer cells.
    Zabaglo L; Ormerod MG; Parton M; Ring A; Smith IE; Dowsett M
    Cytometry A; 2003 Oct; 55(2):102-8. PubMed ID: 14505315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test.
    Adams DL; Stefansson S; Haudenschild C; Martin SS; Charpentier M; Chumsri S; Cristofanilli M; Tang CM; Alpaugh RK
    Cytometry A; 2015 Feb; 87(2):137-44. PubMed ID: 25515318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased sensitivity for detection of micrometastases in bone-marrow/peripheral-blood stem-cell products from breast-cancer patients by negative immunomagnetic separation.
    Naume B; Borgen E; Nesland JM; Beiske K; Gilen E; Renolen A; Ravnås G; Qvist H; Kåresen R; Kvalheim G
    Int J Cancer; 1998 Nov; 78(5):556-60. PubMed ID: 9808522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in circulating carcinoma cells in patients with metastatic prostate cancer correlate with disease status.
    Moreno JG; O'Hara SM; Gross S; Doyle G; Fritsche H; Gomella LG; Terstappen LW
    Urology; 2001 Sep; 58(3):386-92. PubMed ID: 11549486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomagnetic techniques for the enrichment and detection of isolated breast carcinoma cells in bone marrow and peripheral blood.
    Naume B; Borgen E; Beiske K; Herstad TK; Ravnås G; Renolen A; Trachsel S; Thrane-Steen K; Funderud S; Kvalheim G
    J Hematother; 1997 Apr; 6(2):103-14. PubMed ID: 9131439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection and clinical significance of circulating tumor cells in peripheral blood of breast cancer patients].
    Cai QQ; Huang HQ; Lin TX; Jiang WQ
    Ai Zheng; 2005 Jul; 24(7):837-41. PubMed ID: 16004811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicolor detection of rare tumor cells in blood using a novel flow cytometry-based system.
    Watanabe M; Uehara Y; Yamashita N; Fujimura Y; Nishio K; Sawada T; Takeda K; Koizumi F; Koh Y
    Cytometry A; 2014 Mar; 85(3):206-13. PubMed ID: 24327318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of cytokeratin 20 mRNA in the peripheral blood of patients with colorectal cancer by immunomagnetic bead enrichment and real-time reverse transcriptase-polymeras chain reaction.
    Guo J; Xiao B; Jin Z; Qin L; Chen J; Chen H; Zhang X; Liu Z
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1279-84. PubMed ID: 16048578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enrichment and detection of circulating tumor cells by immunomagnetic beads and flow cytometry.
    Hu L; Chen X; Chen M; Fang J; Nie J; Dai H
    Biotechnol Lett; 2021 Jan; 43(1):25-34. PubMed ID: 32959190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of carcinoma cells in peripheral blood samples of patients with advanced breast carcinoma using RT-PCR amplification of CK7 and MUC1.
    Felton T; Harris GC; Pinder SE; Snead DR; Carter GI; Bell JA; Haines A; Kollias J; Robertson JF; Elston CW; Ellis IO
    Breast; 2004 Feb; 13(1):35-41. PubMed ID: 14759714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of MUC1-expressing mammary carcinoma cells in the peripheral blood of breast cancer patients by real-time polymerase chain reaction.
    de Cremoux P; Extra JM; Denis MG; Pierga JY; Bourstyn E; Nos C; Clough KB; Boudou E; Martin EC; Müller A; Pouillart P; Magdelénat H
    Clin Cancer Res; 2000 Aug; 6(8):3117-22. PubMed ID: 10955792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of disseminated tumor cells in peripheral blood of patients with breast cancer: correlation to nodal status and occurrence of metastases.
    Taubert H; Blümke K; Bilkenroth U; Meye A; Kutz A; Bartel F; Lautenschläger C; Ulbrich EJ; Nass N; Holzhausen HJ; Koelbl H; Lebrecht A
    Gynecol Oncol; 2004 Jan; 92(1):256-61. PubMed ID: 14751168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
    Okegawa T; Nutahara K; Higashihara E
    J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.